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Proper neural crest development and migration is
critical during embryonic development, but the
molecular mechanisms regulating this process
remain incompletely understood. Here, we show
that the protein kinase Erk, which plays a central
role in a number of key developmental processes in
vertebrates, is regulated in the developing neural
crest by p21-activated protein kinase 1 (Pak1).
Furthermore, we show that activated Erk signals by
phosphorylating the transcription factor Gata6 on a
conserved serine residue to promote neural crest
migration and proper formation of craniofacial struc-
tures, pigment cells, and the outflow tract of the
heart. Our data suggest an essential role for Pak1
as an Erk activator, and Gata6 as an Erk target, dur-
ing neural crest development.
INTRODUCTION
The Erk signaling pathway is central to a number of cellular pro-
cesses such as transcription, cell proliferation, and differentia-
tion (Krens et al., 2008). Erks have been shown to mediate cell
migration during gastrulation of zebrafish embryos (Krens
et al., 2008). In addition, pharmacologic inhibition of the Erk
activator Mek in zebrafish results in defective craniofacial devel-
opment, outflow tract blockage in the heart with concomitant
pericardial edema, and increased vascular permeability (Anasta-
saki et al., 2012; Bolcome and Chan, 2010). Conversely, overac-
tivation of Erk by expression of constitutively active Shp2, Sos,
Ras, Raf, or Mek mutants is also associated with a variety of
heart defects in zebrafish (Jopling et al., 2007; Razzaque et al.,
2012; Runtuwene et al., 2011; Stewart et al., 2010). Despite its
central role, the identities of the upstream activators of Erk and
its downstream targets that regulate developmental pathways
are poorly understood.
p21-activated kinase1 (Pak1) is a serine/threonine kinase that
acts downstreamof the small GTPases Cdc42 andRac1 to regu-
late a multitude of cellular processes including transcription,
translation, cell motility, survival, proliferation, and organization
of the cytoskeleton (Arias-Romero and Chernoff, 2008). Some
of the functions of Pak1 are related to its ability to serve as a scaf-
fold protein (Higuchi et al., 2008); however, the bulk of its activ-
ities are believed to be due to its ability to phosphorylate various350 Developmental Cell 29, 350–359, May 12, 2014 ª2014 Elsevier Intargets (Bokoch, 2003; Dummler et al., 2009). Among the most
firmly established substrates of Pak1 are c-Raf and Mek1, and
we and others have shown that loss of Pak1 activity leads to
loss of c-Raf, Mek1, and subsequent Erk activation in many
cell types (Arias-Romero and Chernoff, 2008). While Pak1 also
hasmany other substrates besides c-Raf andMek1 that mediate
its cellular effects, recent genetic and pharmacologic data show
that the Pak/Mek/Erk signaling axis is essential for transforma-
tion in a K-ras-driven mouse model of skin cancer (Chow et al.,
2012).
Here, we report that knockdown of Pak1 in zebrafish embryos
causes defects in neural crest development, characterized by a
linear heart tube and outflow tract blockage, impaired melano-
phore development and migration, and aberrant cartilage struc-
ture. These developmental defects are accompanied by loss of
Erk activity and can be suppressed by expression of activated
Mek1 or by a phosphomimic form of an Erk substrate, the tran-
scription factor Gata6. These results establish a molecular
signaling pathway fromPak1 toMek/Erk to Gata6 that is required
for proper development of the neural crest.
RESULTS
Pak1 Expression in Zebrafish
To examine the expression pattern of pak1 in zebrafish, we per-
formed a whole-mount in situ hybridization throughout develop-
ment. Pak1 expression was ubiquitous at the one-cell stage
through 100% epiboly (Figure 1A). By 24 hr postfertilization
(hpf), pak1 was expressed in low levels throughout the embryo
with more prominent expression in the central nervous system
and intersomitic vessels. By 48 hpf, pak1 expression was easily
detected in the central nervous system and weakly detected in
the intersomitic vessels and heart. To further demonstrate
expression, we used RT-PCR to detect pak1 expression at mul-
tiple developmental stages. This experiment revealed that pak1
was expressed from the one-cell stage to 72 hpf (Figure 1B).
Knockdown and Rescue of pak1 in the Developing
Zebrafish
To determine the contribution of pak1 to development, we de-
signed a morpholino (MO) against the intron/exon splice site of
pak1 and injected this MO at the one-cell stage. Both RT-PCR
and immunoblot showed that the MO was effective at knocking
down pak1 through 48 hpf (Figures 1C and 1D). The MO was
then titrated to determine the minimal doses needed to give reli-
able phenotypes (Figures S1A and S1B available online; Table
S1). Control MOs containing mismatches to the pak1 targetc.
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or protein expression (Figures 1C and 1D). In addition, we tested
ATG MOs against pak1 and splice site MOs against both pak2a
and pak2b. The pak1 ATG MO-injected morphants showed a
phenotype similar to that of the pak1 splice site MO. In contrast,
pak2a MO showed hemorrhaging in the head, while pak2b MO
displayed no observable phenotype, similar to published reports
(Figure S1D and Table S2) (Buchner et al., 2007).
At 24 hpf, the vastmajority of pak1morphants displayed one of
two phenotypes: moderate (78%) or severe (18%), with the
moderate phenotype consisting of significant developmental
defects including a general loss of tissue, cell death in the
head, a curled body axis, and pericardial edema (Figures 1E
and 1F). These phenotypes were also observed at 48 hpf, with
gross morphological defects in the heart, along with no/slowed
circulation (Figure 1E). Such moderate morphants had normal
heart rates, indicating a lack of gross conductance defects
(data not shown). A small percentage of severe pak1morphants
displayed a significant loss of tissue, cell death, and loss of cir-
culation (Figure 1E).
The severe pak1 morphants displayed an extensive loss of
tissue throughout the body, with an enhanced cell death through
the head region compared to wild-type (WT) embryos and
control MO-injected embryos (Figures 1E and S1E). These
effects were also seen in p53 null embryos injected with pak1
MOs, indicating that the tissue loss was not secondary to a
general p53-mediated apoptosis induced by pak1 MO injection
(Figure S1F).
As the pak1morphant phenotype was so striking at 24 hpf, we
assessed the patterning of the embryo during gastrulation and
tissue specification. Convergence-extension (CE) movements
were not notably perturbed by pak1 MOs, with a normal body
axis ratio (Figures S1G and S1H) and normal bilateral staining
of hgg1 and dlx3 markers at 10 hpf (Figure S1I). The expression
and distribution of bone morphogenetic protein 4 (bmp4), which
is involved in the specification of ventral cell fates, was not
affected by knockdown of pak1 (Figure S1J). Similarly, expres-
sion of the dorsal-specific gene goosecoid (gsc), which is ex-
pressed in the Spemann’s organizer, and expression of the
mesendodermal marker notail (ntl) (Figure S1J), were also
normal. These markers indicate that knockdown of pak1 did
not alter CE or the formation of the dorsal-ventral axis in early
zebrafish embryos.
Pak1 is highly conserved by sequence homology between hu-
mans and zebrafish, with approximately 81% sequence identity
and approximately 87% sequence similarity. To determine if the
function of pak1 is conserved between species, we injected one-
cell-stage embryos with human Pak1mRNA along with the pak1
MO directed against zebrafish pak1. The combined injection of
the pak1 MO and human Pak1 mRNA caused a statistically sig-
nificant rescue of injected embryos when compared to pak1MO
alone (Figures 1G and 1H). When a kinase-dead version of hu-
man Pak1 was used, the morphant phenotype was not sup-
pressed. Zebrafish pak1, but not pak2a or 2b, also efficiently
rescued the pak1 morphant phenotype, These data show that
the biological function of pak1 is conserved between humans
and zebrafish, that these functions are not redundant with those
of pak2, and that protein kinase activity is essential for Pak1
function in development.DeveHeart Defects in Pak1 Morphants
To determine the nature of the cardiovascular defects of pak1
morphants, we performed an in situ hybridization using the early
cardiac marker nkx2.5. The expression of nkx2.5 at 24 hpf was
identical in WT and pak1 morphant embryos, suggesting that
the initial stages of cardiogenesis, including cardiomyocyte
specification and initial heart tube formation, were unaffected
(Figure 2A). Defects in the pak1 morphant heart appeared by
48 hpf, when themorphant heart failed to loop (Figure 2B). Immu-
nostaining with MF20 and S46 antibodies, marking the heart and
the atrium, respectively, provided further evidence of the looping
failure and also showed a defect in atrium growth (Figure 2C). In
addition to the failure to loop, the pak1 morphant heart was
unable to allow blood to exit as shown in pak1 MO-injected
Tg(Gata1:DsRed) embryos. In pak1 morphants, blood did not
flow freely but was seen only in the heart, suggesting an outflow
blockage (Figure 2D). Sectioning through the outflow tract re-
vealed a severe constriction (Figure 2E). pak1 morphants did
not stain with Eln2 antibodies, a marker of the bulbous arteriosis
(Miao et al., 2007; Zhou et al., 2011) (Figure 2F) or the fluorescent
nitric oxide indicator 4,5-diaminofluorescein diacetate (DAF-
2DA) (Grimes et al., 2006; data not shown). These data suggest
that pak1morphants have normal initial cardiogenesis, including
heart tube formation, but that the heart fails to properly loop or
develop the bulbous arteriosis. In these settings, blood is unable
to flow and regurgitates into the atrium.
Pak1 Signaling Is Crucial in Neural Crest Specification
and Migration
Given the outflow tract defects we observed, we hypothesized
that pak1 morphants are defective in neural crest differentiation
and migration. To test this idea, we first examined expression of
sox10 and foxD3, markers for undifferentiated neural crest cells,
at the 16- to 18-somite stage. Sox10 and foxD3 both displayed
elevated expression levels in the pak1 morphants suggestive
of a block in differentiation (Figure 2G). To examine the migration
of the neural crest cells, we performed in situ hybridization for
crestin. At the 16- to 18-somite stage, crestin staining shows
reduced migration in the neural crest posterior to the otic pla-
code. At the 20-somite stage, crestin staining displayed a loss
of migration of the neural crest throughout the body and tail
(Figure 2G).
Neural crest cells differentiate and become various cell and
tissue types throughout the body, such as melanocytes, carti-
lage, and smooth muscle. By 2 dpf, the amount of melanocytes
in the pak1 morphants was significantly reduced compared to
that of WT embryos (Figures 2H and 2J). Correspondingly,mitfa,
a marker for differentiated melanophores, showed reduced
staining in the pak1morphants (Figure 2I). Consistent with these
data, the migration of melanophores was decreased in the pak1
morphants at 2 dpf (Figure 2K). Pak1 morphants also displayed
severe abnormalities in craniofacial cartilage, including defects
in Meckel’s and ceratohyal cartilage and subsequent pharyngeal
arches (Figure 2L). These defects were rescued by expression of
zebrafish Pak1 (Figure S2). These data suggest that pak1 is
required for normal neural crest migration.
To determine if the effects of Pak1 depletion on neural crest
development are cell autonomous, we injected embryos with
mRNA encoding a specific peptide inhibitor of group I Paks,lopmental Cell 29, 350–359, May 12, 2014 ª2014 Elsevier Inc. 351
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Figure 1. Pak1 Is Required for Normal Development of Zebrafish
(A) Transcripts for pak1 were detected by whole-mount in situ hybridization at the stages indicated. epib, epiboly.
(B) Expression of pak1 at various stages in development by RT-PCR.
(C) RT-PCR analysis of pak1 transcripts in morphants compared to WT and MM-injected embryos at 24 and 48 hpf.
(D) Immunoblot analysis of Pak1 in morphants compared to WT at 24 and 48 hpf.
(E) Representative images of the moderate (MO moderate) and severe (MO severe) pak1 knockdown phenotypes as compared to the WT and MM-injected
embryos at 24 hpf and 48 hpf.
(legend continued on next page)
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A Role for Pak1 in Heart Developmentthe Pak inhibitor domain (PID) (Zhao et al., 1998) or the negative
control, PID L107F. PID-injected, but not PID L107F-injected,
embryos resembled the pak1 morphant (Figure 2M, upper
panel). We then expressed the PID in developing neural crest
or heart, using the sox10 (Dutton et al., 2008) and the cmlc
(Huang et al., 2003) promoters, respectively. Expression of the
PID, but not the inactive PID L107F, in neural crest resulted in
a phenotype similar to that of the pak1 morphant (Figure 2M,
lower panels). Expression of either PID or PID L107F from the
cmlc promoter did not visibly perturb development (Figure 2M).
These data suggest that Pak1 signals primarily in the neural crest
during zebrafish embryonic development.
Suppression of Pak1 Morphant Phenotype with
Activated Mek
Similar to pak1 morphants, embryos 1–3 dpf treated with CI-
1040 displayed small heads, curled body axis, and pericardial
edema (Figure 3A; Figure S3A). In addition, like pak1morphants,
CI-1040-treated embryos lacked circulation (Figure 3B), sug-
gesting that Pak1 may be signaling through the Mek/Erk
pathway in cardiac development. To further test this theory, we
injected a constitutively active form of Mek1 (Mek DD), along
with pak1 MO, into one-cell-stage embryos. Mek DD was intro-
duced into zebrafish through a heat-shock-inducible system to
bypass the developmental defects caused by constitutively
active Mek at the one-cell stage. When induced by heat shock,
virtually all cells expressed the transgene (Figure S3B). WT and
pak1 morphant embryos were not affected by the heat shock
treatment (Figure 3C). The addition of active Mek toWT embryos
also caused no significant defects in development, with or
without heat shock treatment (Figure 3C). Pak1 morphants in-
jected with Mek DD, however, displayed a significant rescue at
48 hpf on heat shock treatment. These embryos displayed a par-
tial rescue of body axis, less pericardial edema, and a return of
circulation (Figures 3C and 3D).
We next analyzed phosphorylated Erk levels by immunohisto-
chemistry in the pak1 morphants at 24 hpf. Phosphorylated Erk
was reduced in the head and heart regions of the pak1 mor-
phants (Figure 3E). It is interesting that phosphorylated Erk
was not uniformly reduced throughout the body of the embryo
but maintained high levels in the trunk and tail. Total phospho-
Mek1 levels were also reduced in the morphants (Figure 3F).
Pak1 Signals through Gata6 in Development
A number of studies have linked Gata6 to heart formation (Kodo
et al., 2009; Lepore et al., 2006; Peterkin et al., 2005; Pikkarainen
et al., 2004). In zebrafish, MO knockdown of Gata6 induced
a striking phenotype characterized by a lack of circulation by
3–4 dpf and formation of a nonlooped heart tube (Holtzinger
and Evans, 2005). Since Gata6 has previously been shown to
represent an Erk target in Ras-transformed mammalian cells
(Adachi et al., 2008), and the phosphorylation site in human
Gata6 is conserved in the zebrafish protein, we hypothesized
that Pak1 might signal through the Mek/Erk pathway to activate(F) Quantification of pak1 knockdown phenotype at 24 hpf. *p < 0.0001.
(G) Morphology of embryos injected with the indicated MOs plus mRNA for WT
zPak2b.
(H) Quantitation of phenotypes at 24 hpf. *p < 0.0001.
DeveGata6 in zebrafish. To evaluate this hypothesis, we first showed
that Erk can phosphorylate zebrafish Gata6 in vitro and that this
phosphorylation is abolished if the putative phosphorylation site
(Ser 265) is changed to alanine (data not shown). Next, we coin-
jected embryos with a pak1 MO and an expressing vector
bearing the equivalent of a constitutively phosphorylated form
of Gata6 (S265D) or a nonphosphorylatable form of Gata6
(S265A). At 48 hpf, pak1 morphants injected with Gata6 S265D
appeared significantly different from the control pak1 mor-
phants, with a lack of developmental defects and a return of cir-
culation (Figures 4A and 4B). In comparison, embryos injected
with WT Gata6 or Gata6 S265A did not show evidence of rescue
but rather retained a phenotype indistinguishable from that of
control pak1 morphants (Figures 4A and 4B; data not shown).
We next performed electrophoretic mobility shift assays
(EMSAs) to test the DNA-binding activity of Gata6. We showed
that WT Gata6 was able to bind its target DNA in a dose-depen-
dent manner (Figure 4C). We then tested the effect of phos-
phorylation on Gata6 DNA binding. Recombinant Gata6 was
incubated in the presence or absence of Erk and ATP and then
tested for activity by EMSA. We found that phosphorylated of
Gata6 by Erk increased its ability to bind DNA 4-fold (Figures
4C and 4D). To further test the effects of phosphorylation on
Gata6 activity, human embryonic kidney 293 cells were trans-
fected with WT Gata6 and a luciferase reporter plasmid contain-
ing either a promoter with a Gata6 binding element or a mutant,
nonbinding element (Figure 4E). WT Gata6 induced transcription
of the luciferase gene about 22 times over the mutant promoter.
To determine if the phosphorylation status of Ser 265 plays a role
in Gata6 activation, we then introduced the Gata6 SA and SD
mutants into the luciferase assay. Gata6 SD displayed 3-fold
more transcriptional activity than WT Gata6 or Gata6 SA (Fig-
ure 4F). These results are consistent with the idea that phosphor-
ylation of Ser 265 activates Gata6. To further test this idea, we
used Gata6 reporters to assess the effects of constitutively
active Pak1 (Pak L107F) or Mek (Mek DD) on Gata6 activity.
Both activated Pak1 and Mek1 significantly stimulated Gata6-
responsive luciferase reporter activity over background (Fig-
ure 4G). The stimulatory effect of active Pak1 was attenuated
by coexpression of Gata6 S265A (Figure 4H). These results
further suggest that Erk signals through Gata6 by phosphory-
lating this transcription factor at Ser 265, resulting in its activa-
tion. Finally, to assess the ability of Gata6 to rescue neural-crest
defects, we coinjected the sox10-PID and heat-shock-inducible
Gata6 (SD or SA) into embryos and examined the resulting phe-
notypes.We found that Gata6 SD, but not Gata6 SA, suppressed
the developmental effects of PID expression in the neural crest
(Figure 4I).
DISCUSSION
Aberrant activation of Erk is associated with a number of devel-
opmental defects in vertebrate organisms (Bromberg-White
et al., 2012; Sala et al., 2012; Zenker, 2011). Previous studiesof kinase-dead human Pak1 (hPak1), WT zebrafish Pak1 (zPak1), zPak2a, or
lopmental Cell 29, 350–359, May 12, 2014 ª2014 Elsevier Inc. 353
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Figure 2. Pak1 Morphants Display Cardiac and Neural Crest Defects
(A) Transcript expression of nkx2.5 shown by in situ hybridization at 20 somites.
(B and C) Pak1 morphant heart does not loop at 48 hpf as shown by (B) Tg(cmlc2:GFP) immunofluorescence and (C) staining with MF20 and S46 antibodies.
(D) Ventral images of 48 hpf Tg(Gata1:DsRed) show a cardiac outflow tract blockage with no blood flow throughout the head vasculature in the pak1morphants
(MO) compared to MM embryos (MM). Arrows point to cardiac outflow tract.
(E) Transverse sections of the cardiac outflow tract in MO- and MM-injected embryos stained with H&E. Arrows point to the cardiac outflow tract.
(F) Eln2 staining of WT and pak1 morphant embryos. Arrow indicates region of Eln positivity. Eln Abs, Eln2 antibodies.
(legend continued on next page)
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A Role for Pak1 in Heart Developmenthave shown that chemical inhibition of epidermal growth factor
receptor or Mek in zebrafish causes heart abnormalities, includ-
ing pericardial edema, restricted blood flow, and an abnormal
body axis (Anastasaki et al., 2012). The ability of activated Mek
to suppress the pak1 morphant phenotype is consistent with
previous studies in other organisms and indicates that Pak1
acts through Mek to control development (Figure 3C). It is inter-
esting that, while pak1morphants display low levels of active Erk
in the head and heart, phosphorylated Erk levels were not
markedly reduced elsewhere in the body (Figure 3E), suggesting
either a redundancy in Pak function or a different mechanism
for Erk activation in the embryonic trunk and tail. This feature
may account for the differences in tail morphology in pak1
morphants versus CI-1040-treated embryos (Figure 3A).
Perhaps the most striking findings in our study are the pheno-
typic effects of Pak1 inhibition in the neural crest (Figure 2M) and
the suppression of the pak1morphant phenotype by expression
of an activated form of the Erk substrateGata6 (Figure 4A). These
results suggest that Gata6 activation represents a prime function
for Pak1, via Erk, in zebrafish development, most likely acting in
the neural crest. In this context, it is interesting to note that Pak1
has been reported to play a role in neural crest migration in Xen-
opus (Bisson et al., 2012) and that Gata6 has been reported to
affect cardiac neural crest migration by activating transcription
of semaphorin 3C (Kodo et al., 2009; Lepore et al., 2006). In
mice, Gata6 deletion in the neural crest leads to defective
morphogenetic patterning of the cardiac outflow tract and aortic
arch (Lepore et al., 2006). In man, mutations in GATA6 are asso-
ciated with a variety of congenital heart problems, including
outflow tract malformations (Kodo et al., 2009), septal defects
(Wang et al., 2012), atrial fibrillation (Li et al., 2012), and tetralogy
of Fallot (Huang et al., 2013). Our data suggest that Gata6
function affects development of the outflow tract as well as other
neural crest derivatives in zebrafish. For example, in addition to
outflow tract obstruction, pak1 morphants displayed deranged
cartilage formation and lower numbers of melanocytes, as well
as failure of these melanocytes to migrate to their proper loca-
tions. These data imply that a circuit from Pak1 to Mek/Erk to
Gata6 ultimately regulates neural crest development and migra-
tion. Whether failure to activate this signaling circuit also under-
lies the craniofacial and cardiac abnormalities seen in Cdc42
neural crest knockout mice remains to be determined (Liu
et al., 2013).
The role of Pak1 in Erk signaling and in neural crest migration
described here point to potential relationships to human disease
syndromes. Defects in neural crest are associated with cardiofa-
ciocutaneous syndromes such as Noonan’s syndrome, Costello
syndrome, and LEOPARD syndrome. Notably, germline muta-
tions that result in constitutive Erk activation cause many(G) In situ hybridization for sox10 and foxD3 at 16–18 somites (lateral and crania
hybridization for crestin at the 16- to 18-somite stage and the 20-somite stage. N
the lateral view.
(H) Trunk images of pak1 morphants lacking melanophores at 2 dpf.
(I) In situ hybridization for mitfa.
(J) Quantification of melanophores at 2 dpf. Error bars indicate a significant diffe
(K) Quantification of melanophore migration in pak1morphants compared to MM
(L) Cartilage staining (Alcian blue) at 6 dpf.
(M) Top:WT embryos were injected with either PID (Pak inhibitor) or PID L107F (ina
were injected with expression vectors encoding PID or PID L107F driven by the so
Deveof these overlapping developmental syndromes, sometimes
termed ‘‘Rasopathies’’ (Anastasaki et al., 2012). These abnormal
developmental syndromes have several features in common,
including heart defects, skin abnormalities, and distinctive facial
features. How Erk overactivation leads to these phenotypes is
not known; however, in a zebrafish model of LEOPARD syn-
drome, it has been suggested that downregulation of foxd3
and sox10 by Erk is important for normal neural crest migration,
with subsequent effects on development (Stewart et al., 2010).
Here, we suggest that Gata6 activation by Erk plays a central
role in the zebrafish development related to neural crest migra-
tion. For these reasons, the characterization of a Pak-Mek-Erk-
Gata6 signaling module not only helps clarify an important
developmental molecular pathway but also may point to poten-
tial new therapeutic targets in Rasopathy syndromes.
EXPERIMENTAL PROCEDURES
Zebrafish Stocks and Embryo Collection
WT AB and transgenic zebrafish lines were maintained in the Zebrafish Core
Facility of the Fox Chase Cancer Center under standard conditions (Kimmel
et al., 1995). Embryo collection and maintenance were carried out as
described elsewhere (Rhodes et al., 2009). All experiments involving zebrafish
were reviewed and approved by the Institutional Animal Care and Use
Committee at Fox Chase Cancer Center.
MO Design and Analysis
The pak1MO (GeneTools, LLC) was designed to target the pak1 exon1-intron1
boundary (50- GCATCACTCACTCTTGTCTCCTC-30). Embryos were injected
as described elsewhere (Lightcap et al., 2009). Effects on zebrafish pak1
(accession number NM_201328) splicing was analyzed by RT-PCR using the
One Step RT-PCR kit (QIAGEN). Primers were designed to bind to the first
exon (forward) and the second exon (reverse) of zebrafish pak1: 50-ACTGG
GATCCATGTCAGACAATGGGGAGTAGAG-30 and 50-CGTCTGGAGTAATCG
AGCCCACTGCTCAGGCAT-30. Cyclophilin was used as a loading control.
pak1 ATG MO, pak2a MO, and pak2b MO were designed as previously pub-
lished (Buchner et al., 2007; Lightcap et al., 2009). Unless otherwise indicated,
MOs were used at 1.49 ng per embryo, and numbers represent the total from
three batches of embryos, performed and analyzed independently.
Immunoblot Analysis
Zebrafish embryos were collected at noted time points and deyolked as
described elsewhere (Link et al., 2006). Membranes were blocked with 5%
BSA overnight and probed using the SNAP i.d. System (Millipore). Membranes
were incubated with 1:1,000 Pak1 antibodies (1:1,000) for 15 min. Membranes
were washed with Tris-buffered saline Tween and incubated with horseradish-
peroxidase-conjugated antibodies (1:10,000).
Zebrafish Rescue Experiments
Human PAK1 cDNA was subcloned into BamHI and EcoRI sites of the pCS2
vector. Human transcripts were transcribed in vitro using the mMessage
Machine kit (Ambion). RNAs were injected into one-cell-stage zebrafish em-
bryos as previously elsewhere (Lightcap et al., 2009). Mek-DD (S219D,
S223D) and Gata6 (S265A or S265D) were subcloned into pSGH2 vector.l views). Arrows point to cranial neural crest expression in lateral view. In situ
ote lack of migration of neural crest in cranial view (arrows) and down the tail in
rence with p < 0.0001. *p < 0.0001.
-injected embryos. Error bars indicate a significant difference with p < 0.0001.
ctive Pak inhibitor) mRNA. Embryos are shown at 48 hpf. Bottom:WT embryos
x10 promoter or the cmlc promoter, as indicated. Images were taken at 48 hpf.
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Figure 3. Pak1 Signals through the Erk Pathway in Heart Development
(A) Comparison of chemical inhibition ofMek and pak1morphants at 3 dpf. WT embryoswere placed in eggwater containing dimethyl sulfoxide (DMSO) or 0.5 mM
CI-1040 at the one-cell stage. The water was changed every 24 hr with new drug. The embryos were analyzed for gross morphology and presence or absence of
circulation.
(B) Quantification of circulation seen with Mek inhibition at 48 hpf.
(C) Representative images of 48 hpf pak1morphants rescued by an active form of Mek (Mek DD). An inducible Mek1 DD expression plasmid was coinjected with
the pak1 MO at the one-cell stage, followed by heat shock at 24 hpf as indicated.
(D) Quantification of circulation seen with the addition of Mek DD.
(E) Immunohistochemistry for phosphorylated Erk.
(F) Immunoblot for phosphorylated Mek in whole embryos injected with either MM or pak1 MO.
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Figure 4. Active Gata6 Can Compensate for Loss of Pak1
(A) Representative images of pak1 morphants that have been rescued by the addition of an active form of Gata6 (Gata6 SD) but not by the inactive mutant
(Gata6 SA).
(B) Quantification of circulation in the Gata6 rescue. The indicated inducible Gata6 expression plasmids were coinjected with pak1 MO at the one-cell stage,
followed by heat shock at 24 hpf as indicated.
(C) Fluorescent EMSA showing dose-dependent binding of WTGata6 to aGATA-containing DNA template (EMSA) as well as effects of Gata6 phosphorylation on
DNA binding.
(legend continued on next page)
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Developmental Cell
A Role for Pak1 in Heart DevelopmentThe plasmid was coinjected at 5 ng/ml with 1 mM pak1MO into AB embryos at
the one-cell stage. At 24 hpf, the fish were heat shocked at 38C for 1 hr to
induce the expression of the protein of interest and green fluorescent
protein (GFP). Embryos were examined 2 hr after heat shock to determine
the expression of GFP. At 48 hpf, embryos were examined for rescue of the
phenotype. PID or PID L107F expression driven by the sox10 or cmlc pro-
moters were injected into one-cell-stage embryos at a concentration of
30 ng/ml. At 48 hpf, the embryos were examined for phenotypes.
Sectioning and Staining
AB embryos were injected with the pak1 MO at the one-cell stage. At 48 hpf,
the embryos were fixed in 4% paraformaldehyde. The embryos were then
frozen in optimal cutting temperature compound and cut into 12-mm trans-
verse sections. Sections were stained with hematoxylin and eosin (H&E) for
visualization. Eln2 antibodies were used to visualize the bulbous arteriosis
(Zhou et al., 2011). DAF-2DA staining was performed as previously published
(Grimes et al., 2006).
Imaging
Dechorionated embryos were placed on a glass depression slide in 1%meth-
ylcellose, and morphology was assessed visually using a light transmission
Nikon SMZ 1500. Representative images were recorded using a Nikon digital
sight DS Fi1 camera.
Whole-Mount In Situ Hybridization, Immunohistochemistry, and
Cartilage Staining
Whole-mount in situ hybridization and immunohistochemistry was performed
as described elsewhere (Bolli et al., 2011; Koshida et al., 2005; Yelon et al.,
1999). p-Erk (Cell Signaling #9101) was used as primary antibody, and 3,30 di-
aminobenzidine was used for visualization. Cartilage staining was preformed
as described elsewhere (Kimmel et al., 1998).
Luciferase and EMSA Assays
Assayswere performed bymanufacturer’s protocols, using the PromegaDual-
Glo Luciferase Assay System and the Molecular Probes EMSA Kit E33075. For
EMSA assays, the oligonucleotide contained a Gata6 site (50-CAAAGGGCC
GATGGGCAGATAGAGGAGAGACAGGA-30) (Molkentin et al., 1994). Lucif-
erase assays were carried out using Gata6 reporter constructs (Kodo et al.,
2009).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and two tables and can
be found with this article online at http://dx.doi.org/10.1016/j.devcel.2014.
04.003.
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